Head-to-head decision matrix
Daily gum-line photo scoring for cleaning-gap prevention best fits the Operator Builder (42/100 fit), while Recovery-percentile tracker for orthopedic surgery patients best fits the Research Strategist (36/100 fit). Choose by the founder advantage you can actually bring to the first validation sprint.
Between cleanings, patients have no way to notice early gum inflammation or plaque buildup, so problems are only caught months later at the next visit when they have already worsened.
After orthopedic surgery, patients cannot tell whether their pain, swelling, and stiffness are normal, so they flood surgeon offices with 'is this normal?' calls while staff have no objective benchmark to reassure or escalate.
Validation criteria
Bars use the existing report visual scale, with each criterion scored out of 10.
Demand looks weak because the report has 2 source-backed signal(s), an editorial confidence of 50/100, and a defined buyer in Consumer oral-health monitoring.
Demand looks thin because the report has 2 source-backed signal(s), an editorial confidence of 54/100, and a defined buyer in Orthopedic post-operative recovery tracking.
Problem severity is thin when the buyer pain, customer value, and dream-outcome scores are combined.
Problem severity is thin when the buyer pain, customer value, and dream-outcome scores are combined.
Willingness to pay is weak; the model has a monetization hypothesis, but it must still be proven through paid pilots or explicit pricing objections.
Willingness to pay is weak; the model has a monetization hypothesis, but it must still be proven through paid pilots or explicit pricing objections.
No source-backed direct match is recorded yet, so saturation risk is treated as unknown rather than proof of novelty.
No source-backed direct match is recorded yet, so saturation risk is treated as unknown rather than proof of novelty.
Feasibility is thin for a moderate build if the MVP is limited to the first measurable workflow.
Feasibility is weak for a high build if the MVP is limited to the first measurable workflow.
Revenue: $250K-$2M ARR potential if the wedge proves budget urgency and becomes a recurring workflow.
GTM: Start with manual concierge output, direct outreach, and community proof before paid acquisition.
Execution: Execution is moderate; the main constraint is staying narrow enough for a first proof loop.
Revenue: $250K-$2M ARR potential if the wedge proves budget urgency and becomes a recurring workflow.
GTM: Start with manual concierge output, direct outreach, and community proof before paid acquisition.
Execution: Execution is high; the main constraint is staying narrow enough for a first proof loop.
Daily gum-line photo scoring for cleaning-gap prevention best fits the Operator Builder (42/100 fit), while Recovery-percentile tracker for orthopedic surgery patients best fits the Research Strategist (36/100 fit). Choose by the founder advantage you can actually bring to the first validation sprint.